Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Prepping For Brexit With Notified Body Switch Could Be Unnecessary Expense, BSI Warns

Executive Summary

While there are some warnings that UK medical device companies should be jumping ship, and taking worst-case Brexit scenarios seriously, major notified body BSI believes there is too much scaremongering, and that a less disruptive EU-UK agreement is likely.


Related Content

BSI Touts 'Very Short' Waiting Times For Migrating Certificates From UK To Netherlands
Brexit: Where Things Stand For Medtech
EU Regulatory Reads, January 2018: Brexit And New Reg-Deadline Minefields
MedTech Europe CEO Shakes Up Industry On Brexit In Mission To Help It
Commission Spells Out Non-Recognition Of UK Organizations In Future EU





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts